Brent Rutland
Chief Tech/Sci/R&D Officer chez KORU MEDICAL SYSTEMS, INC.
Postes actifs de Brent Rutland
Sociétés | Poste | Début | Fin |
---|---|---|---|
KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Historique de carrière de Brent Rutland
Anciens postes connus de Brent Rutland
Sociétés | Poste | Début | Fin |
---|---|---|---|
LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 01/09/2018 | 01/10/2022 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/08/2016 | 01/07/2017 |
Formation de Brent Rutland
Texas A&M University | Undergraduate Degree |
University of Houston | Masters Business Admin |
University of North Carolina at Chapel Hill | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
KORU MEDICAL SYSTEMS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Brent Rutland
- Expérience